A study to assess the relationship between Agni (factor responsible for digestion and metabolism) and Arogya (health) using questionnaire and Ayurveda intervention among adults

STUDY ON RELATIONSHIP BETWEEN AGNI AND AROGYA IN THE CONTEXT OF â??BALAMAAROGYAMAAYUSHCHA PRAANAASHCHAAGNOU PRATISHTHITAAHâ??-A CROSS SECTIONAL SURVEY AND RANDOMIZED CLINICAL STUDY - SRAACSRCT

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/09/046060

Enrollment

Registered

2022-09-30

Start date

Unknown

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified Health Condition 2: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. On the basis of classical symptoms of Vicharchika Roga mentioned in Ayurveda classics i.e. Kandu (itching), Pidaka (small raised eruptions), Shyava (black-brownish), Srava (profuse oozing), Raji (marked linings), Ruja (painful), Rukshata (dry lesions) etc. 2.Symptoms of eczema described in modern science 3. EASI score with mild to moderate eczema (1.1 to 7 for mild, 7.1 to 21.0 for moderate) 4. Willing to participate

Exclusion criteria

Exclusion criteria: (1) Subjects having any other serious systemic disease like congestive cardiac failure, chronic renal failure, tuberculosis, carcinoma etc. forth last one year will be excluded. (2) Patients having skin disorder other than VICARCIKA. (3) Patient not Willing to participate in the study (4) Patient having skin disorder due to reaction. (5) Subjects having age below 20 and above 60 years (6) Patients having EASI score less than 1.1 and more than 21. (7) Patients who have completed participation in any other clinical trial during the past six months. (8) Any other condition which the investigator thinks may jeopardize the study.

Design outcomes

Primary

Measure	Time frame
To evaluate role of Agni on maintenance of health and manifestation of diseases in general and specifically in VICARCIKA (Eczema) among adults.Timepoint: Evaluation of role of Agni on maintenance of health and on manifestation of diseases in general will be accessed at the base line of survey study. Evaluation of role of Agni on manifestation of VICARCIKA (Eczema) will be accessed on end of 30 days of clinical trial.	—

Measure

Time frame

To evaluate role of Agni on maintenance of health and manifestation of diseases in general and specifically in VICARCIKA (Eczema) among adults.Timepoint: Evaluation of role of Agni on maintenance of health and on manifestation of diseases in general will be accessed at the base line of survey study. Evaluation of role of Agni on manifestation of VICARCIKA (Eczema) will be accessed on end of 30 days of clinical trial.

—

Secondary

Measure	Time frame
1. Response to treatment and compare add on effect of Shunthi churna (Agni treatment) to the Gandhaka Rasayana and Tuvaraka taila (skin specific treatment) in patients of VICARCIKA (Eczema) of 20-60 yrs. 2. To assess any association of Agni with modern parameters (L.F.T. and B. Sugar) among adults.Timepoint: 1. Response to treatment and compare add on effect of Shunthi churna (Agni treatment) to the Gandhaka Rasayana and Tuvaraka taila (skin specific treatment) in patients of VICARCIKA (Eczema) of 20-60 yrs will be accessed at the end of 30 days after clinical trial. 2. Any association of Agni with modern parameters (L.F.T. and B. Sugar) among adults will be accessed at base line of survey study.	—

Measure

Time frame

1. Response to treatment and compare add on effect of Shunthi churna (Agni treatment) to the Gandhaka Rasayana and Tuvaraka taila (skin specific treatment) in patients of VICARCIKA (Eczema) of 20-60 yrs. 2. To assess any association of Agni with modern parameters (L.F.T. and B. Sugar) among adults.Timepoint: 1. Response to treatment and compare add on effect of Shunthi churna (Agni treatment) to the Gandhaka Rasayana and Tuvaraka taila (skin specific treatment) in patients of VICARCIKA (Eczema) of 20-60 yrs will be accessed at the end of 30 days after clinical trial. 2. Any association of Agni with modern parameters (L.F.T. and B. Sugar) among adults will be accessed at base line of survey study.

—

Countries

India

Contacts

Public ContactDr Mahesh Vyas

All India Institute of Ayurveda, New Delhi

drmaheshkvyas@gmail.com9426953118

Outcome results